Hjem › Amyloidose › Missouri
Amyloidose kliniske forsøg i Missouri
7 studier for Amyloidose søger deltagere på steder i Missouri.
Byer i Missouri
Officiel studietekst (engelsk)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Kansas City
- Research Site, St Louis
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, St Louis
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, St Louis
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07358078Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- St. Luke's Hospital of Kansas City, Kansas City
- Washington University in St. Louis, St Louis
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
- Washington University in St. Louis, St Louis
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 29. jul. 2026 · NCT07695701A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, St Louis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT07081646MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- St. Luke's Hospital, Kansas City
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.